Products for Research Use Only
RegisterLogin

Napyradiomycin B4

CAT: 0804-HY-N12740Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N12740Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Napyradiomycin B4 is a Napyradiomycin derivative, which inhibits the RANKL-induced MEK-ERK signaling pathway. Napyradiomycin B4 attenuates osteoclastogenesis and prevents alveolar bone destruction in experimental periodontitis[1].
UNSPSC
12352005
Target
ERK; MEK
Type
Natural Products
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/napyradiomycin-b4.html
Solubility
10 mM in DMSO
Smiles
Cl[C@](C(C1=C(O)C=C(O)C=C1C2=O)=O)(C[C@H](C(C)(O3)C)Cl)[C@]23C[C@H]4C(C)([C@H](CC[C@@]4(O)C)Cl)C
Molecular Formula
C25H31Cl3O6
Molecular Weight
533.87
References & Citations
[1]Kim JA, et al., Napyradiomycin B4 Suppresses RANKL-Induced Osteoclastogenesis and Prevents Alveolar Bone Destruction in Experimental Periodontitis. ACS Pharmacol Transl Sci. 2024 Apr 3;7 (4) :1023-1031.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported

Related Products

CatalogName
HY-N14412Napyradiomycin A2
HY-136824Napyradiomycin A1
HY-N14844Napyradiomycin C2
HY-N14806Napyradiomycin C1
HY-N14805Napyradiomycin B3
HY-N14804Napyradiomycin B2
HY-N14802Napyradiomycin B1
HY-N12329-01Fumonisin B4
HY-P991231DI-B4
HY-N13983Arylomycin B4

Alternative Products

CatalogName
BIBR1067Napyradiomycin A
TN10956-01Napyradiomycin B2
462139Napyradiomycin A1
TN11036-01Napyradiomycin B1
GTR19255880-01Napyradiomycin B3
TN11329-01Napyradiomycin C1
TN10334-01Napyradiomycin C2
TN10091-01Napyradiomycin A2
NQB02731-01Napyradiomycin sr
TN11175-01Napyradiomycin B4

Popular Products